Vision and Strategy
Braasch Biotech strives to continuously build on our position as the world leader in somatostatin vaccines. The Company has vaccine product candidates with great potential for both financial returns and social returns.
We have a focused strategy on addressing the large, unmet human and animal medicine need for more GH and IGF-1 treatment alternatives. Our vision is to create a large diversified pipeline of novel vaccine treatment options for: obesity, type 2 Diabetes , growth deficiency in children, livestock productivity, and companion animal obesity.
In the longer term, we will investigate new vaccination treatments for IGF-1 responsive human neurological disorders such as Rett's Syndrome.